Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
AstraZeneca
Colorcon
Chubb
Merck
Baxter
Boehringer Ingelheim
Julphar

Generated: July 20, 2018

DrugPatentWatch Database Preview

Fenofibric acid - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for fenofibric acid and what is the scope of fenofibric acid freedom to operate?

Fenofibric acid
is the generic ingredient in one branded drug marketed by Aralez Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for fenofibric acid. Six suppliers are listed for this compound.
Pharmacology for fenofibric acid
Synonyms for fenofibric acid
017F890
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoicacid
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropionic acid
2-[4-(4-Chloro-benzoyl)-phenoxy]-2-methyl-propionic acid (Fenofibric acid)
2-[4-(4-Chlorobenzoyl)-phenoxy]-2-methylpropionic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic Acid
2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid (Fenofibric Acid)
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid, 95%
2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid
2-methyl-((4'-4-chlorobenxoly)-2-phenoxy)propionic acid
2-methyl-((4'-p-chlorobenzoyl)-2-phenoxy)propionic acid
42017-89-0
4CH-014888
AB0011864
AB01563028_01
AC-22277
AC1L228K
AJ-08119
AK117112
AKOS015889489
alpha 1081
AN-6566
API0000561
API0025995
AX8069177
BDBM28700
BGF9MN2HU1
BRN 2058973
C17H15ClO4
CCG-213311
CCRIS 7302
CHEBI:83469
CHEMBL981
CL23223
CS-2965
D0NF1U
DB13873
DTXSID8041030
EINECS 255-626-9
F1011
feno-fibric acid
Fenofibrate impurity B, European Pharmacopoeia (EP) Reference Standard
Fenofibrate Related Compound B, United States Pharmacopeia (USP) Reference Standard
FENOFIBRIC ACID
Fenofibric acid, analytical standard
FNF Acid
FT-0082391
FT-0600402
GTPL2662
HY-B0760
I01-2052
J10251
KB-51864
KS-00000MR0
KS-1234
LF 153
LF 178 acid
LS-121251
M-1210
MCULE-1938576029
MFCD00792461
MolPort-000-002-475
MQOBSOSZFYZQOK-UHFFFAOYSA-N
NSC 281318
NSC-281318
NSC281318
OR026035
Procetofenic acid
Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-
Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-
RL03621
s4527
SC-15796
SCHEMBL16377
ST2416089
ST50998899
Trilipix
UNII-BGF9MN2HU1
W-106287
ZINC1984

US Patents and Regulatory Information for fenofibric acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-002 Aug 14, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
QuintilesIMS
US Army
McKinsey
Cipla
Fuji
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.